
Ro
Top 100
Illustrative curve — no price history on file for this company.
Funding
Raised a $150M round on Feb 15, 2022, bringing the total raised amount to $1B.
Returns Calculator
A $10,000 investment at Series C round (2020) would today be worth:
$46,667
4.7×the original amount
Illustrative · based on reported post-money valuations
Hiring Signal
Based on public job postings · updated monthly
Latest news
Public companies tied to Ro
About Ro
Ro is a New York-based direct-to-patient telehealth company, founded in 2017, that diagnoses patients online and delivers prescription treatments and ongoing care through vertically integrated pharmacies and at-home lab testing. It operates consumer brands including Roman (men's health), Rory (women's health), and a weight-loss program, and has become a leading player in GLP-1 obesity care, partnering with drugmakers such as Eli Lilly and Novo Nordisk. Ro reported roughly $598M in annualized revenue in 2024, up about 66% year over year.











